Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PRXL > SEC Filings for PRXL > Form 8-K on 17-Sep-2013All Recent SEC Filings

Show all filings for PAREXEL INTERNATIONAL CORP

Form 8-K for PAREXEL INTERNATIONAL CORP


17-Sep-2013

Change in Directors or Principal Officers


Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 11, 2013, the Compensation Committee, or the Committee, of the Board of Directors of PAREXEL International Corporation, or the Company, approved targets under the Company's Management Incentive Plan, or MIP, for the fiscal year ending June 30, 2014, or Fiscal Year 2014. Under the MIP for Fiscal Year 2014, incentives for our Senior Vice President and Chief Financial Officer and the executive officers disclosed in our Proxy Statement, dated October 26, 2012, or, collectively, the Named Executive Officers, are based on the achievement of corporate, business unit and personal goals. The corporate goals set by the Committee include specific earnings per share, or EPS, and backlog objectives, and the business unit objectives are based on achieving predetermined business unit operating margin, or BOM, and customer satisfaction objectives. Personal goals collectively constitute 20% of each executive's Fiscal Year 2014 MIP opportunity. For Fiscal Year 2014, corporate and business unit goals were set to have a roughly 80% chance of attainment based on budgets, market conditions and historical factors. For executives to be awarded any payment under the corporate EPS or BOM elements of the Fiscal Year 2014 MIP, at least 90% of the targeted value has to be attained. For executives to be awarded any payment under the backlog element of the Fiscal Year 2014 MIP, 100% or more of the targeted value has to be attained. Over-achievement of certain goals enables an individual to earn more than 100% of the targeted MIP. However, to the extent any such overachievement payment would cause the Company to miss its targets, that payment is reduced.
The metrics for Fiscal Year 2014 bonus opportunities under the Company's MIP for the Named Executive Officers, excluding personal goals, are as follows: Josef von Rickenbach has a target bonus equal to 100% of base salary and can achieve a maximum bonus of 120.0% of his target bonus (or 120.0% of his base salary), based upon backlog and EPS metrics; Ingo Bank has a target bonus equal to 55% of base salary and can achieve a maximum bonus of 127.5% of his target bonus (or 70.1% of his base salary), based upon backlog and EPS metrics; Mark A. Goldberg has a target bonus equal to 65% of base salary and can achieve a maximum bonus of 118.8% of his target bonus (or 77.2% of his base salary), based upon backlog, EPS and customer satisfaction metrics; Ulf Schneider has a target bonus equal to 45% of base salary and can achieve a maximum bonus of 122.5% of his target bonus (or 55.1% of his base salary), based upon backlog and EPS metrics; Joseph Avellone has a pro-rated target bonus equal to 33.75% of base salary and can achieve a maximum bonus of 125.0% of his target bonus (or 42.2% of his base salary), based upon backlog, EPS, BOM and customer satisfaction metrics; and James F. Winschel, Jr. has a target bonus equal to 55% of base salary and can achieve a maximum bonus of 127.5% of his target bonus (or 70.1% of his base salary), based upon backlog and EPS metrics.
In addition, the Committee granted awards of restricted stock and restricted stock units to certain of the Named Executive Officers that include vesting provisions that are based upon the achievement of Company financial performance metrics and the passing of time.
On September 11, 2013, the Committee approved new terms of employment between the Company and Joseph Avellone, Senior Vice President, Clinical Research Services. Effective October 1, 2013, Dr. Avellone's title will change to Executive Vice President, he will work approximately eight hours per week, and his new responsibilities will focus on business development strategy and client-focused activities. His annual salary will be $110,000 and he will be eligible to participate in the Company's MIP.


  Add PRXL to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PRXL - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.